newsFirst patient dosed in Phase I trial of universal HIV vaccine Pennvax-GP8 September 2015 | By Victoria WhiteThe trial will measure immune responses following administration of Pennvax-GP in four groups of healthy subjects receiving the vaccine with and without an immune activator (IL-12)...
newsPromising Phase 3 results for E/C/F/TAF regimen presented at IAS22 July 2015 | By Victoria WhiteDetailed 48-week data from a Phase 3 study evaluating E/C/F/TAF regimen in patients with HIV-1 was presented at the 8th IAS Conference...
newsHIV-1 maturation inhibitor BMS-955176 demonstrates positive new Phase IIa results22 July 2015 | By Victoria WhiteBristol-Myers Squibb has announced additional Phase IIa data for BMS-955176, a novel investigational agent designed to prevent the maturation of HIV-1...
newsFDA grants Breakthrough Therapy Designation to Bristol-Myers Squibb’s BMS-66306821 July 2015 | By Victoria WhiteThe FDA has granted Breakthrough Therapy Designation to BMS-663068 for the treatment of HIV-1 infection in heavily treatment-experienced adult patients...
newsEC approves Evotaz for the treatment of HIV-1 infection in adults16 July 2015 | By Victoria WhiteThe EC has approved Evotaz tablets in combination with other antiretroviral agents for the treatment of HIV-1 infected adults...
newsViiV Healthcare and Desano manufacturing agreement will bring competitive supply of dolutegravir to China3 July 2015 | By Victoria WhiteViiV Healthcare and Desano Pharmaceuticals have announced a strategic manufacturing agreement to enable production of dolutegravir in China...
newsGilead submits NDA for single tablet regimen for HIV containing rilpivirine, emtricitabine and tenofovir alafenamide (R/F/TAF)2 July 2015 | By Victoria WhiteGilead Sciences has submitted a NDA to the FDA for an investigational, once-daily single tablet regimen for the treatment of HIV-1 infection...
newsCuba becomes the first country to eliminate mother-to-child transmission of HIV and syphilis1 July 2015 | By Victoria WhiteCuba has become the first country in the world to receive validation from WHO that it has eliminated mother-to-child transmission of HIV and syphilis...
newsNew STI figures released by Public Health England23 June 2015 | By Victoria WhiteLatest figures published by Public Health England (PHE) show there were 439,243 sexually transmitted infections (STIs) reported in England in 2014...
newsRoche to provide HIV diagnostic solutions to Global Fund18 June 2015 | By Victoria WhiteRoche has been selected to provide HIV-1 viral load and early infant diagnostic technologies for the Global Fund...
newsEMA validates Marketing Application for fixed-dose combination of emtricitabine and tenofovir alafenamide (F/TAF) for HIV treatment29 May 2015 | By Victoria WhiteGilead’s MAA for a fixed-dose combination of emtricitabine and tenofovir alafenamide (F/TAF) has been fully validated and is now under evaluation by the EMA..
newsStarting antiretroviral treatment early improves outcomes for HIV-infected individuals28 May 2015 | By Victoria WhiteA trial has found that HIV-infected individuals have a lower risk of developing AIDS or other serious illnesses if given antiretroviral drugs sooner...
newsMechanism of action of First-in-class anti-HIV drug, ABX464, published13 April 2015 | By Victoria WhiteABIVAX, a biotechnology company developing first-in-class anti-viral drugs and vaccines, has announced publication of the mechanism of action of ABX464...
newsGilead submits New Drug Application for F/TAF for the treatment of patients with HIV8 April 2015 | By Victoria WhiteGilead has submitted a NDA to the FDA for an investigational fixed-dose combination of F/TAF for the treatment of HIV-1 infection...
newsEU Disease Lens brings visibility and insight into the most critical diseases24 March 2015 | By Victoria WhiteJanssen Health Policy Centre (Janssen Pharmaceutica NV) today unveiled the EU Disease Lens: a digital dashboard that brings insight into 15 major diseases...
